Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18414767 | ETHYL {[N'-(3-CHLOROPHENYL)-N-(2,4-DICHLOROBENZOYL) CARBAMIMIDOYL]SULFANYL}ACETATE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALIS (BOISD.) | January 2024 | August 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18414749 | ETHYL {[N'-(3-CHLOROPHENYL)-N-(2,4-DICHLOROBENZOYL) CARBAMIMIDOYL]SULFANYL}ACETATE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALIS (BOISD.) | January 2024 | September 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18404706 | THERAPEUTIC METHODS USING BUPROPION HYDROBROMIDE | January 2024 | July 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18483283 | ETHYL {[N'-(3-CHLOROPHENYL)-N-(2,4-DICHLOROBENZOYL) CARBAMIMIDOYL]SULFANYL}ACETATE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALIS (BOISD.) | October 2023 | April 2024 | Allow | 6 | 1 | 1 | No | No |
| 18219446 | COMPOSITIONS OF ASPIRIN AND KETAMINE | July 2023 | August 2024 | Abandon | 13 | 1 | 1 | No | No |
| 18218178 | Micronutrient composition to prevent and reverse protein glycation during oxidative stress in human | July 2023 | February 2025 | Abandon | 20 | 3 | 1 | Yes | No |
| 18118479 | MODIFIED RELEASE FORMULATIONS AND USES THEREOF | March 2023 | August 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18100616 | MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS | January 2023 | February 2025 | Abandon | 25 | 3 | 1 | No | No |
| 17936562 | COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS | September 2022 | May 2024 | Abandon | 20 | 1 | 0 | No | No |
| 17902440 | COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT | September 2022 | August 2024 | Allow | 24 | 1 | 1 | Yes | No |
| 17878259 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | August 2022 | September 2023 | Abandon | 14 | 1 | 1 | No | No |
| 17845012 | MESOSTIGMATA MITE CONTROL AGENT | June 2022 | July 2024 | Allow | 25 | 1 | 1 | Yes | No |
| 17741707 | COSMETIC MASK FOR APPLICATION TO THE SKIN, AND METHOD FOR APPLYING SAME | May 2022 | July 2024 | Abandon | 26 | 1 | 1 | No | No |
| 17721864 | COMPOSITE MATERIAL INCLUDING A THERMOPLASTIC POLYMER, A PEST FOOD MATERIAL, AND A PESTICIDE | April 2022 | October 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17690611 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | March 2022 | May 2023 | Allow | 14 | 2 | 1 | Yes | No |
| 17667746 | PHARMACEUTICAL FORMULATION | February 2022 | November 2024 | Allow | 33 | 2 | 0 | No | No |
| 17646805 | STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION | January 2022 | June 2024 | Allow | 29 | 1 | 2 | Yes | No |
| 17545628 | NON-ABLATIVE MULTI-LAYER COATINGS THAT PREVENT WATER-DERIVED DAMAGE, CORROSION, AND DETERIORATION FROM BIOLOGICAL CHEMICAL PROCESSES | December 2021 | January 2023 | Allow | 14 | 1 | 1 | Yes | No |
| 17608905 | SYNERGISTIC BIOACTIVE COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | November 2021 | May 2024 | Allow | 30 | 5 | 0 | Yes | No |
| 17513192 | METHODS OF PROTECTING SEEDS FROM OXIDANTS AND MICROORGANISMS | October 2021 | December 2023 | Allow | 25 | 1 | 0 | Yes | No |
| 17500332 | PHARMACEUTICAL COMPOSITIONS COMPRISING CHROMIUM AND CARBOHYDRATE BLOCKERS | October 2021 | December 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17499498 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | October 2021 | April 2024 | Allow | 30 | 2 | 0 | No | No |
| 17497117 | Natural Component Tick Repellent | October 2021 | September 2024 | Abandon | 35 | 1 | 1 | No | No |
| 17490616 | MODIFIED RELEASE FORMULATIONS AND USES THEREOF | September 2021 | December 2022 | Allow | 14 | 1 | 1 | Yes | No |
| 17478268 | COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES | September 2021 | December 2024 | Abandon | 39 | 2 | 1 | No | No |
| 17465972 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | September 2021 | April 2022 | Allow | 8 | 1 | 1 | Yes | No |
| 17349916 | SOLID DOSAGE FORMS OF PALBOCICLIB | June 2021 | October 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17348471 | PHARMACEUTICAL COMPOSITION AND USE | June 2021 | July 2024 | Allow | 37 | 2 | 1 | Yes | No |
| 17413358 | COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND USE THEREOF FOR PROMOTING HAIR GROWTH | June 2021 | February 2024 | Allow | 33 | 1 | 1 | Yes | No |
| 17308007 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | May 2021 | March 2023 | Allow | 22 | 3 | 1 | Yes | No |
| 17237361 | METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN | April 2021 | September 2023 | Abandon | 29 | 0 | 1 | No | No |
| 17229200 | HYALURONATE COMPOSITIONS AND SOFT TISSUE FILLERS | April 2021 | September 2023 | Allow | 29 | 1 | 1 | No | No |
| 17227370 | HEALTH-CARE PRODUCT COMPOSITION FOR ENRICHING ASTHENIC DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF | April 2021 | January 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17215988 | Low pH Skin Care Composition and Methods of Using the Same | March 2021 | October 2023 | Allow | 30 | 1 | 1 | Yes | No |
| 17300136 | Novel formulation of meloxicam | March 2021 | October 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17275849 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | March 2021 | February 2024 | Allow | 35 | 1 | 1 | No | No |
| 17198283 | Constituent combination for treating stress | March 2021 | January 2024 | Abandon | 34 | 1 | 1 | No | No |
| 17198366 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | March 2021 | June 2021 | Allow | 3 | 1 | 1 | Yes | No |
| 17191582 | METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS | March 2021 | January 2025 | Abandon | 46 | 3 | 1 | Yes | No |
| 17183110 | ANTIVIRAL VINYL-CHLORIDE RESIN COMPOSITION, ANTIVIRAL SHEET OF VINYL-CHLORIDE RESIN, PROCESS FOR PRODUCING THE SAME, INTERIOR DECORATIVE SHEET, PROCESS FOR PRODUCING INTERIOR DECORATIVE SHEET, INTERIOR DECORATIVE SHEET OF POLY(VINYL CHLORIDE) RESIN, ANTIVIRAL WALLPAPER, AND PROCESS FOR PRODUCING ANTIVIRAL WALLPAPER | February 2021 | January 2024 | Allow | 34 | 1 | 1 | Yes | No |
| 17156809 | PHARMACEUTICAL COMPOSITIONS OF SITAGLIPTIN | January 2021 | April 2024 | Abandon | 39 | 2 | 1 | No | No |
| 17149105 | COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT | January 2021 | April 2025 | Abandon | 51 | 4 | 0 | Yes | No |
| 17142600 | SPATIAL INSECT REPELLENT COMPOSITIONS | January 2021 | August 2023 | Allow | 31 | 2 | 1 | Yes | No |
| 17136162 | COMPOSITION FOR INCREASING PRODUCTIVITY IN PLANTS | December 2020 | October 2023 | Allow | 34 | 2 | 1 | No | No |
| 17126878 | THERMOPLASTIC MATERIALS HAVING BENEFICIAL PROPERTIES AND PROCESSES FOR PROVIDING THE SAME | December 2020 | July 2023 | Abandon | 31 | 0 | 1 | No | No |
| 17059124 | METHODS FOR PROMOTING HAIR GROWTH | November 2020 | May 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17100652 | TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION | November 2020 | June 2023 | Allow | 31 | 1 | 1 | Yes | No |
| 16952845 | METHODS FOR PREVENTION AND TREATMENT OF UROGENITAL ATROPHY OF MENOPAUSE BY CONTACT VASODILATORS | November 2020 | July 2023 | Abandon | 32 | 5 | 1 | No | No |
| 17057058 | COMPOSITION OF MULTIVITAMIN FOR STIMULATING GASTROINTESTINAL SYSTEM MOTILITY AND PREPARATION METHOD THEREFOR | November 2020 | July 2024 | Allow | 44 | 2 | 1 | Yes | No |
| 16949792 | INSECT BAIT COMPOSITION AND METHODS OF USE OF THE SAME | November 2020 | July 2024 | Abandon | 44 | 2 | 1 | No | No |
| 17093715 | METHOD FOR PREVENTING OR REDUCING GROWTH OF A MICROORGANISM ON A SURFACE | November 2020 | April 2023 | Allow | 29 | 1 | 1 | Yes | No |
| 17090837 | COSMETIC COMPOSITION AND PREPARATION METHOD | November 2020 | September 2023 | Abandon | 35 | 1 | 1 | No | No |
| 17066172 | ADJUVANT COMPOSITION CONTAINING ALUMINUM AND VACCINE COMPOSITION CONTAINING THE SAME | October 2020 | June 2023 | Abandon | 32 | 1 | 1 | No | No |
| 17061321 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | October 2020 | April 2021 | Allow | 7 | 1 | 1 | Yes | No |
| 17038920 | APPLICATION OF METHYLMALONIC ACID IN THE PREPARATION OF NEMATODE INSECTICIDES | September 2020 | March 2023 | Allow | 30 | 1 | 0 | Yes | No |
| 17025156 | COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS | September 2020 | November 2022 | Abandon | 26 | 1 | 0 | No | No |
| 16981893 | PESTICIDE | September 2020 | November 2023 | Abandon | 38 | 2 | 1 | No | No |
| 17021124 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | September 2020 | January 2021 | Allow | 4 | 1 | 1 | Yes | No |
| 16975642 | HERBICIDALLY ACTIVE BICYCLIC BENZAMIDES | August 2020 | January 2025 | Allow | 53 | 1 | 1 | Yes | No |
| 16963563 | AGRICULTURAL AND HORTICULTURAL FUNGICIDE COMPOSITION | July 2020 | October 2022 | Allow | 26 | 1 | 0 | No | No |
| 16963021 | METHOD AND COMPOSITION FOR COLOURING AN EYEBROW COMPRISING AN ORGANIC ACID | July 2020 | February 2023 | Allow | 31 | 1 | 1 | No | No |
| 16922411 | METHOD FOR SCAVENGING HYDROGEN PEROXIDE AND REGULATING GASTROINTESTINAL FUNCTION BY USING DRINKING WATER COMPRISING SILICON DIOXIDE | July 2020 | November 2022 | Abandon | 29 | 1 | 1 | No | No |
| 16918687 | METHIONINE METABOLIC PATHWAY INHIBITORS | July 2020 | December 2022 | Allow | 30 | 1 | 1 | No | No |
| 16955745 | DITHIAZOCANE COMPOUNDS FOR THE COSMETIC USE THEREOF | June 2020 | September 2022 | Abandon | 27 | 0 | 1 | No | No |
| 16954917 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | June 2020 | December 2022 | Abandon | 30 | 0 | 1 | No | No |
| 16772537 | PLANT GROWTH REGULATION | June 2020 | July 2023 | Allow | 37 | 2 | 1 | Yes | No |
| 16892641 | MODIFIED RELEASE FORMULATIONS AND USES THEREOF | June 2020 | June 2021 | Allow | 13 | 2 | 0 | Yes | No |
| 16891491 | Low pH Skin Care Composition and Methods of Using the Same | June 2020 | February 2021 | Allow | 8 | 1 | 1 | Yes | No |
| 16886239 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | May 2020 | April 2021 | Allow | 11 | 1 | 1 | Yes | No |
| 16767398 | HERBICIDAL COMBINATIONS | May 2020 | January 2025 | Abandon | 55 | 6 | 1 | Yes | No |
| 16765678 | Fungicidal Compositions | May 2020 | October 2022 | Allow | 28 | 1 | 0 | Yes | No |
| 16764461 | PROCESS FOR PERMANENT WAVING KERATIN FIBERS | May 2020 | August 2024 | Abandon | 51 | 2 | 1 | No | Yes |
| 15931910 | APIXABAN FORMULATIONS | May 2020 | June 2021 | Abandon | 13 | 0 | 1 | No | No |
| 16871831 | ANTIMICROBIAL PARTICLES AND SANITIZATION METHODS | May 2020 | December 2024 | Abandon | 55 | 3 | 1 | No | No |
| 16866136 | PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS | May 2020 | September 2023 | Abandon | 41 | 2 | 1 | No | No |
| 16860188 | DISINFECTION FORMULATION AND DISINFECTION METHOD | April 2020 | February 2023 | Allow | 34 | 2 | 1 | Yes | No |
| 16759310 | All-in-one lyophilized multivitamin emulsion for parenteral application | April 2020 | July 2023 | Allow | 39 | 4 | 1 | Yes | No |
| 16852603 | EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF | April 2020 | September 2022 | Abandon | 29 | 1 | 1 | No | No |
| 16853164 | COMPOSITE MATERIAL INCLUDING A THERMOPLASTIC POLYMER, A PEST FOOD MATERIAL, AND A PESTICIDE | April 2020 | February 2022 | Allow | 22 | 2 | 0 | Yes | No |
| 16755396 | BENZIMIDAZOLE COMPOUNDS AS AGRICULTURAL CHEMICALS | April 2020 | October 2022 | Abandon | 30 | 0 | 1 | No | No |
| 16754910 | PESTICIDE COMPOSITION CONTAINING THIDIAZURON AND POLYGLUTAMIC ACID | April 2020 | October 2022 | Allow | 30 | 1 | 0 | No | No |
| 16754856 | METHOD OF PREPARATION OF FLORASULAM | April 2020 | May 2024 | Allow | 49 | 3 | 0 | Yes | No |
| 16841861 | HYALURONATE COMPOSITIONS AND SOFT TISSUE FILLERS | April 2020 | March 2021 | Allow | 11 | 2 | 1 | Yes | No |
| 16649627 | Pyrimidin-4-Carbamate or Urea Derivatives As Herbicides | March 2020 | December 2023 | Abandon | 45 | 5 | 1 | No | No |
| 16644518 | COSMETIC MASK FOR APPLICATION TO THE SKIN, AND METHOD FOR APPLYING SAME | March 2020 | June 2022 | Abandon | 27 | 1 | 1 | No | No |
| 16810207 | Hair Care Compositions Comprising Malodor Reduction Compositions | March 2020 | September 2021 | Allow | 18 | 1 | 0 | Yes | No |
| 16810222 | Hair Care Compositions Comprising Malodor Reduction Compositions | March 2020 | September 2021 | Allow | 18 | 1 | 0 | Yes | No |
| 16809714 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | March 2020 | September 2020 | Allow | 6 | 1 | 1 | Yes | No |
| 16810233 | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer | March 2020 | January 2022 | Allow | 22 | 1 | 1 | Yes | No |
| 16638450 | PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES | February 2020 | February 2022 | Allow | 24 | 2 | 1 | No | Yes |
| 16777866 | TRIMEGESTONE (TMG) FOR TREATMENT OF PRETERM BIRTH | January 2020 | December 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16774709 | Antimicrobial Compositions with Effervescent Agents | January 2020 | April 2023 | Abandon | 39 | 3 | 1 | No | No |
| 16751811 | PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | January 2020 | July 2021 | Allow | 18 | 2 | 0 | No | No |
| 16748873 | COMPOSITION BASED ON TANNINS AND SAPONINS FOR CONTROLLING PLANT PARASITIC NEMATODES | January 2020 | September 2022 | Abandon | 32 | 1 | 1 | No | No |
| 16727610 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | December 2019 | March 2022 | Abandon | 27 | 1 | 1 | No | No |
| 16725316 | COMPOSITION FOR TREATING WOUNDS, DERMATITIS, INFLAMMATION, AND IRRITATION | December 2019 | July 2023 | Allow | 43 | 4 | 1 | Yes | No |
| 16625281 | ANTIMICROBIAL MIXTURE CONTAINING 4-(3-ETHOXY-4-HYDROXYPHENYL)BUTAN-2-ONE AND AN ORGANIC ACID COMPOUND, AND COSMETIC COMPOSITION CONTAINING SAME | December 2019 | April 2023 | Abandon | 40 | 4 | 1 | Yes | No |
| 16723230 | COSMETIC COMPOSITION AND ITS USE, DERMOCOSMETIC FORMULATION | December 2019 | September 2022 | Allow | 32 | 1 | 1 | No | No |
| 16718293 | INHIBITION OF EXOCYTOSIS AND THE USES THEREOF | December 2019 | December 2022 | Abandon | 36 | 2 | 1 | No | No |
| 16717151 | Personal Care Composition With Increased Vapor Release | December 2019 | August 2021 | Allow | 20 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FRAZIER, BARBARA S.
With a 11.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 15.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner FRAZIER, BARBARA S works in Art Unit 1611 and has examined 799 patent applications in our dataset. With an allowance rate of 45.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner FRAZIER, BARBARA S's allowance rate of 45.3% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by FRAZIER, BARBARA S receive 2.39 office actions before reaching final disposition. This places the examiner in the 82% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by FRAZIER, BARBARA S is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +12.2% benefit to allowance rate for applications examined by FRAZIER, BARBARA S. This interview benefit is in the 52% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 17.5% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 24.6% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 48.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 40% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 47.8% of appeals filed. This is in the 9% percentile among all examiners. Of these withdrawals, 48.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 60.3% are granted (fully or in part). This grant rate is in the 77% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.9% of allowed cases (in the 66% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.6% of allowed cases (in the 50% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.